Cigna is adding three Humira biosimilars to its formulary beginning Sept. 1.
The Latest
Start-up insurer Curative has named Sean Maguire as chief growth officer.
The Blue Cross Blue Shield Association has named Brian Bauer as its new vice president of application solutions.
GLP-1 drugs like Ozempic and Wegovy are contributing to increasing premium rates in Michigan's small-group and individual insurance markets, the Detroit Free-Press reported July 10.
BlueCross BlueShield of Tennessee reported $21.8 million in net income for 2022, down from $521.1 million in 2021.
Leqembi, the newly-approved drug that can slow the progression of Alzhemier's disease, will cost Medicare billions each year, according to an analysis from KFF.
A federal judge in Connecticut has denied a class-action bid against Cigna for allegedly overcharging members for medical equipment and violating its fiduciary duties under the Employee Retirement Income Security Act.
Nearly 50,000 Medicaid enrollees in Ohio are caught in the middle of a commercial reimbursement fight between Anthem Blue Cross Blue Shield and Cincinnati-based Bon Secours Mercy Health.
Vytalize Health, a value-based care company that provides analytics and recommendations to primary care providers, has added two members to its board of directors, including former UnitedHealth Group CEO Dave Wichmann.
A New York judge has temporarily blocked New York City's plan to switch 250,000 retired city employees from traditional Medicare to an Aetna Medicare Advantage plan.